SAILIFE

Sai Life Science Share Price

 

 

Invest in Sai Life Science with 3.11X leverage

Invest with MTF
Sai Life Science live price: ₹1016.75. It opened at ₹1,035 vs previous close ₹1,037; intraday high/low: ₹1,037/₹997. The 50 & 200 DMA stand at ₹924.07/₹853.24.

Sai Life Science Performance

  • Low
  • ₹997
  • High
  • ₹1,037
  • 52 Week Low
  • ₹636
  • 52 Week High
  • ₹1,084
  • Open Price₹1,035
  • Previous Close₹1,037
  • Volume663,176
  • 50 DMA₹924.07
  • 100 DMA₹898.95
  • 200 DMA₹853.24

Investment Returns

  • Over 1 Month + 19.65%
  • Over 3 Month + 18.21%
  • Over 6 Month + 19.51%
  • Over 1 Year + 48.48%

Smart Investing Starts Here Start SIP with Sai Life Science for Steady Growth!

Invest Now

Sai Life Science Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 64.7
  • PEG Ratio
  • 0.5
  • Market Cap Cr
  • 21,532
  • P/B Ratio
  • 9.1
  • Average True Range
  • 39.12
  • EPS
  • 16.02
  • Dividend Yield
  • 0
  • MACD Signal
  • 29.9
  • RSI
  • 61.24
  • MFI
  • 66.62

Sai Life Science Financials

Sai Life Science Technicals

EMA & SMA

Current Price
₹1,016.75
-20.25 (-1.95%)
pointer
  • Bearish Moving Average 2
  • Bullish Moving Average 14
  • 20 Day
  • ₹964.58
  • 50 Day
  • ₹924.07
  • 100 Day
  • ₹898.95
  • 200 Day
  • ₹853.24

Resistance and Support

1016.87 Pivot Speed
  • R3 1,077.03
  • R2 1,057.02
  • R1 1,036.88
  • S1 996.73
  • S2 976.72
  • S3 956.58

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Sai Life Sciences, a leading CRDMO, partners with 280+ global pharma and biotech companies to accelerate NCE small molecule programs. across India, UK, USA, and Japan, it ensures quality and compliance through USFDA-certified facilities.

Sai Life Sciences Ltd has an operating revenue of Rs. 2,169.86 Cr. on a trailing 12-month basis. An annual revenue growth of 16% is outstanding, Pre-tax margin of 13% is healthy, ROE of 7% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 14% and 21% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 5% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 99 which is a GREAT score indicating consistency in earnings, a RS Rating of 90 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 71 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of A is the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Sai Life Science Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-05 Quarterly Results
2025-11-06 Quarterly Results
2025-08-07 Quarterly Results
2025-05-13 Audited Results
2025-02-06 Quarterly Results

Sai Life Science F&O

Sai Life Science Shareholding Pattern

34.7%
27.57%
3.24%
21.41%
5.94%
7.14%

About Sai Life Science

  • NSE Symbol
  • SAILIFE
  • BSE Symbol
  • 544306
  • Managing Director & CEO
  • Mr. Krishnam Raju Kanumuri
  • ISIN
  • INE570L01029

Similar Stocks to Sai Life Science

Sai Life Science FAQs

Sai Life Science share price is ₹1,016 As on 10 March, 2026 | 03:06

The Market Cap of Sai Life Science is ₹21531.5 Cr As on 10 March, 2026 | 03:06

The P/E ratio of Sai Life Science is 64.7 As on 10 March, 2026 | 03:06

The PB ratio of Sai Life Science is 9.1 As on 10 March, 2026 | 03:06

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23